PIQ — Proteomics International Laboratories Share News
0.000.00%
Last trade - 00:00- AU$19.82m
- AU$16.40m
- AU$3.37m
Australia's Proteomics International jumps on new stress test for marathon runners
Australia's Proteomics International jumps on endometriosis panel results
Australia's Proteomics International Laboratories rises on positive cancer study results
Brief: Proteomics International Laboratories Says Terminated Exclusive Licence Agreement With Sonic Healthcare USA
Australia's Proteomics International Laboratories slumps on terminating US licensing deal
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$6.4 Mln
Brief: Proteomics International Laboratories Engages Sales Agency Growth Medics B.V.
Brief: Proteomics International Laboratories Says USA Launch Of PromarkerD Now Likely To Be Delayed
Australia's Proteomics International Labs tumbles on delayed product launch in US
Brief: Proteomics International Laboratories To Raise A$6.5M
Australia's Proteomics Int'l Laboratories drops on discounted placement
Proteomics International up after signing agreement for diabetic kidney disease test
Brief: Proteomics International Laboratories Says Signed A Licence Agreement
Brief: Proteomics International Laboratories Says Australian TGA Decided Not To Include PromarkerD Test In ARTG
Brief: Proteomics International Laboratories Seeks Trading Halt
Brief: Proteomics International Laboratories Posts FY Loss Attributable Of A$6.2 Million
Brief: Proteomics International Laboratories Signs Exclusive Licence Agreement With Sonic Healthcare USA
Australia's Proteomics International up after signing licensing agreement
Brief: Proteomics International Laboratories Seeks Trading Halt